UPM-Kymmene Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C10782
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

UPM-Kymmene Corporation – Strategy, SWOT and Corporate Finance Report
Summary

UPM-Kymmene Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

UPM-Kymmene Corporation (UPM or ‘the company’) operates in forest-based bio industry. The compamy is involved in manufacturing paper (printing and writing papers) and forest based products. Its broad product portfolio includes pulp, fine papers, self-adhesive label materials, label papers, information labelling, energy, biofuels, release liners, timber, graphic paper, plywood and veneer, and wood plastic composites. UPM offers its products to a wide range of industries such as tissue, specialty, graphic papers, and packaging; wood-based renewable diesel and naphtha for fuel distributors and transportation industries; and sawn timber for joinery, packaging, distribution, and construction industries. The company is also produces electricity through hydro, nuclear, and condensing power plants. It operates worldwide. UPM is headquartered in Helsinki, Finland.

Scope

- Detailed information on UPM-Kymmene Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting UPM-Kymmene Corporation in the form of a SWOT analysis
- An in-depth view of the business model of UPM-Kymmene Corporation including a breakdown and examination of key business segments
- Intelligence on UPM-Kymmene Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about UPM-Kymmene Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of UPM-Kymmene Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess UPM-Kymmene Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on UPM-Kymmene Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
UPM-Kymmene Corporation: Company Overview 9
UPM-Kymmene Corporation: Overview and Key Facts 9
UPM-Kymmene Corporation: Overview 9
UPM-Kymmene Corporation: Key Facts 9
UPM-Kymmene Corporation: Key Employees 10
UPM-Kymmene Corporation: Key Employee Biographies 12
UPM-Kymmene Corporation: Major Products and Services 19
UPM-Kymmene Corporation: Company History 20
UPM-Kymmene Corporation: Management Statement 27
UPM-Kymmene Corporation: Locations and Subsidiaries 28
UPM-Kymmene Corporation: Key Competitors 29
UPM-Kymmene Corporation: Company Analysis 30
UPM-Kymmene Corporation: Business Description 30
UPM-Kymmene Corporation: SWOT Analysis 32
UPM-Kymmene Corporation: SWOT Overview 32
UPM-Kymmene Corporation: Strengths 32
UPM-Kymmene Corporation: Weaknesses 33
UPM-Kymmene Corporation: Opportunities 33
UPM-Kymmene Corporation: Threats 34
UPM-Kymmene Corporation: Corporate Financial Deals Activity 36
UPM-Kymmene Corporation: Financial Deals Overview 36
UPM-Kymmene Corporation: Top Deals 2014 – 2018YTD* 37
UPM-Kymmene Corporation: Divestments 38
UPM-Kymmene Corporation: Recent Developments 39
UPM-Kymmene Corporation: News and Events Summary 39
UPM-Kymmene Corporation: Business Expansion 42
UPM-Kymmene Corporation: Contracts 43
UPM-Kymmene Corporation: Corporate Governance 43
UPM-Kymmene Corporation: Financial Performance 44
UPM-Kymmene Corporation: Market Developments 44
UPM-Kymmene Corporation: Red Flags/DistressSignals 45
UPM-Kymmene Corporation: Regulatory and Legal Events 45
UPM-Kymmene Corporation: Strategy and Operations 46
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: UPM-Kymmene Corporation: Key Facts
Table 2: UPM-Kymmene Corporation: Key Employees
Table 3: UPM-Kymmene Corporation: Company History
Table 4: UPM-Kymmene Corporation: Locations and Subsidiaries
Table 5: UPM-Kymmene Corporation: Key Competitors
Table 6: UPM-Kymmene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: UPM-Kymmene Corporation: Top Deals 2014 - 2018YTD*
Table 8: UPM-Kymmene Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 9: UPM-Kymmene Corporation: News and Events Summary
Table 10: UPM-Kymmene Corporation: Business Expansion
Table 11: UPM-Kymmene Corporation: Contracts
Table 12: UPM-Kymmene Corporation: Corporate Governance
Table 13: UPM-Kymmene Corporation: Financial Performance
Table 14: UPM-Kymmene Corporation: Market Developments
Table 15: UPM-Kymmene Corporation: Red Flags/DistressSignals
Table 16: UPM-Kymmene Corporation: Regulatory and Legal Events
Table 17: UPM-Kymmene Corporation: Strategy and Operations

List of Figures
Figure 1: UPM-Kymmene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: UPM-Kymmene Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[UPM-Kymmene Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aprea AB-製薬・医療分野:企業M&A・提携分析
    Summary Aprea AB (Aprea) discovers and develops novel anticancer compounds targeting the tumor suppressor protein p53. The company’s lead drug candidate includes APR-246, an anti-cancer compound that targets and reactivates the tumor suppressor protein p53, inducing programmed cell death in many hum …
  • Intersect ENT Inc (XENT):医療機器:M&Aディール及び事業提携情報
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect …
  • permanent tsb Group Holdings p.l.c.:企業の戦略・SWOT・財務情報
    permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report Summary permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Bloomsbury Publishing Plc (BMY):企業の財務・戦略的SWOT分析
    Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EFU General Insurance Company Limited:企業の戦略・SWOT・財務情報
    EFU General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary EFU General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PEN, Inc. (PENC):企業の財務・戦略的SWOT分析
    PEN, Inc. (PENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ringkjoebing Landbobank A/S:企業の戦略・SWOT・財務情報
    Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report Summary Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company’s products include innovative prescription medicine and drugs, tablets, …
  • PharmaCyte Biotech Inc (PMCB):企業の財務・戦略的SWOT分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …
  • nib Holdings Ltd:企業の戦略・SWOT・財務分析
    nib Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary nib Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Exponent Inc (EXPO):企業の財務・戦略的SWOT分析
    Summary Exponent Inc (Exponent), formerly Failure Analysis Associates Inc, is an engineering and scientific consulting company that provides technical solutions. The company provides engineering services in biomechanics, buildings and structures, biomedical engineering, civil engineering, electrical …
  • Caplin Point Laboratories Ltd (CAPLIPOINT):企業の財務・戦略的SWOT分析
    Summary Caplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures creams, ointments, and other external application products. The company’s products in regulated market include opthalmic products, liquid injections and lyophilised injections. It also offers softgel c …
  • Bristol-Myers Squibb Co (BMY):医療機器:M&Aディール及び事業提携情報
    Summary Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virolo …
  • AIT Austrian Institute of Technology GmbH-医療機器分野:企業M&A・提携分析
    Summary AIT Austrian Institute of Technology GmbH (AIT) is a research and technology institute that provides research development services in various fields. The institute offers research on health and environment, energy, mobility, digital safety and security, and innovation systems. Its health and …
  • ADMA Biologics Inc (ADMA):製薬・医療:M&Aディール及び事業提携情報
    Summary ADMA Biologics Inc (ADMA Biologics) is an integrated biopharmaceutical and specialty immunoglobulin company that develops, produces, and commercializes specialty biologics to treat immune deficiencies and prevent certain infectious diseases. The company develops RI-002, is a specialty plasma …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PharmAbcine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmAbcine Inc (PharmAbcine) is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers products such as bi-specific MAB and lead MAB products. It provides services such as binding test by ELISA, screening by ELISA, mono-phage Ab seque …
  • Biocept Inc (BIOC):医療機器:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆